What's New at the pCPA

December 7, 2023 – In August 2023, the pCPA engaged with clinicians, patient groups and industry to present and hear feedback on a set of principles and conditions for a pCPA Temporary Access Process (pTAP).

The pan-Canadian Pharmaceutical Alliance Corporation (pCPA) Annual General Meeting

To be held at 2125 Victoria Avenue, Regina, SK.  S4P 0S3 on October 25, 2023 at 5 p.m. CST

Notice is hereby given that the first Annual General Meeting of the members of the pan-Canadian Pharmaceutical Alliance Corporation (pCPA) will take place on Wednesday, October 25, 2023 at 5 p.m. CST. Members may participate in person or virtually.

The new three-year pricing initiative for generic drugs will come into effect on October 1, 2023.
The agreement between the pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) builds upon the successes achieved to date with the pan-Canadian Generic Tiered Pricing Framework (TPF) and the pan-Canadian molecules.

The pan-Canadian Pharmaceutical Alliance’s (pCPA) Board of Directors is excited to announce that Douglas Clark will become the first CEO of the newly incorporated organization, effective September 11, 2023

The pCPA is accepting feedback regarding the development of a set of principles and conditions that will inform the negotiation process and potential product listing agreements for any drug products that follow the CADTH time-limited recommendation pathway.